DEHP suppressed the calcium signaling of human nicotinic acetylcholine receptors in human neuroblastoma [46] and induced a decrease in myotube formation in C2C12 cells, associated with reduced MyHC, MyoD and myogenin levels [47]. This evidence concerns the gene MYOD1 and neuroblastoma.